1. Pharmaceutical Industry:
Emerging Trends

2. Top 10 Pharma Ranking: Is this the whole picture?
Rank Company 2004 Rank Company 2011
1 Pfizer 52,516 1 Pfizer 58,523
2 Bristol-Myers Squibb 47,348 2 Sanofi Aventis 40,310
3 GlaxoSmithKline 37,318 3 Merck & Co. 39,811
4 Sanofi-Aventis 31,615 4 Novartis 39,076
5 Novartis 28,247 5 GlaxoSmithKline 36,132
6 Hoffman-La Roche 25,163 6 Hoffman-La Roche 35,568
7 Merck & Co. 22,939 7 AstraZeneca 33,269
8 AstraZeneca 21,427 8 Johnson & Johnson 22,396
9 Abbott Laboratories 19,680 9 Lilly 21,050
10 Johnson & Johnson 19,380 10 Abbott Laboratories 19,894
It looks like the industry has not suffered from
change.
And business has never looked more prosperous.
Nothing is further from the truth. Find out why.
Sources: Med Ad News, 2004 Revenues http://www.contractpharma.com/issues/2007-07/view_features/2007-top-20-pharmaceutical-companies-report/, 2006, 2009; Scrip 100, Dec 2011 with 2010 Revenues in USD millions

3. A changing external
environment.
Can you handle it? The
Economy
Political
Structures Independent Payors Social
/Legal Auditing Bodies Factors
Framework
The
Suppliers
Public
Cultural Distributors / Health
Professionals Demography
Forces Dealers
Technology

4. Opportunities.
Specialty Medicines.
Emerging Economies.
Extent of pricing control.
Customer-centric Services.
Change in Target Audience.
Challenges.
Patent Expirees.
New Business Models.
Manage Corporate Reputation.
It is about the Science.
It should also be about the value you can bring to it.

5. How much Interest the Issue Raises
Pricing
Corporate
Reputation
New Business Models
Change Target Audience
Customer-centric Services
Patent Expiries Specialty Medicines
Emerging Economies
How fast Information on the Issue is Retrieved

6. Pharma Will Sell where Demand is higher: Where?
PRB, US, 2008

7. Pharma Will Sell where Demand is higher: For What?

8. Pharma Will Sell where Demand is higher: Sales 2011

10. How well will Pharma Sell? The R&D Crisis

11. How well will Pharma Sell? Patent Erosion

12. How well will Pharma Sell? Lack of New
Compounds
2010

13. How well will Pharma Sell?
Decreasing New Compound Approvals

14. How well will Pharma Sell? Pricing Pressures

15. How well will Pharma Sell?
Health System Reforms Worldwide
Healthcare becomes more patient - centric
Prescription Decision makers are many and varied
Patients & Independent Auditing Bodies have an Increased

16. How well will Pharma Sell? Technology on Steroids
Connect.
Measure.
Add Value. http://www.imedicalapps.com, 2012

17. How well will Pharma Sell?
Ethics & Corporate Reputation

18. Heath Care is Shaping up to the Needs Worldwide.
How fit is Pharma to respond to growing medical needs?

19. Today we checked the weather and it’s plain sailing.
Not for long.

20. Pharmaceutical
Industry:
Emerging Trends